Enhancement

  • Read more: Illness, Disability, and Dignity

    Illness, Disability, and Dignity

    By Yusuf Lenfest Medicine is meant to heal our ailments and treat our illnesses. Our deep knowledge of the body and the numerous mechanisms that contribute or correlate to good health is considered a triumph of the medical sciences. We can now perform transplants with relative ease, offer prosthetics to those who require them, and…

  • Read more: Two Views About the Gene Editing ‘Breakthrough’ that Are Not Getting Enough Attention (IMHO)

    Two Views About the Gene Editing ‘Breakthrough’ that Are Not Getting Enough Attention (IMHO)

    By I. Glenn Cohen As has now been well-covered in the news, Nature just published a paper from Mitalipov’s lab at the Oregon Health and Science University that used CRISPR/Cas 9 gene editing to correct the MYBPC3 mutation associated with hypertrophic cardiomyopathy — a heart muscle disease that affects 1 in 500 people. The more…

  • Read more: Copenhagen Conference: Legal Perspectives on Synthetic Biology and Gene Editing

    Copenhagen Conference: Legal Perspectives on Synthetic Biology and Gene Editing

    Join us at the Centre for Information and Innovation Law (CIIR) Faculty of Law, University of Copenhagen on 20 November, 2017 to discuss Legal Perspectives on Synthetic Biology and Gene Editing. CALL FOR PAPERS Emerging technologies in Synthetic Biology and Gene Editing offer incredible opportunities and promising solutions to some of the most urgent challenges faced by…

  • Read more: Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    By Timo Minssen I am happy to announce the publication of our new working paper on  “Patenting Bioprinting Technologies in the US and Europe – The 5th element in the 3rd dimension.” The paper, which has  been co-authored by Marc Mimler, starts out by describing the state of the art and by examining what sorts of bioprinting inventions…

  • Read more: Chimeras with benefits? Transplants from bioengineered human/pig donors

    Chimeras with benefits? Transplants from bioengineered human/pig donors

    By Brad Segal In January of this year, Cell published a study modestly titled, Interspecies Chimerism with Mammalian Pluripotent Stem Cells. It reports success bioengineering a mostly-pig partly-human embryo. One day before, Nature published a report that scientists had grown (for lack of a better word) a functioning genetically-mouse pancreas within the body of a…

  • Read more: Westworld and Bioethics

    Westworld and Bioethics

    By I. Glenn Cohen [WARNING: Spoilers below] On Sunday, HBO’s Westworld finished its run. Though I thought some of the early episodes were arguably a bit of a failure as television (and my partner almost jumped off the bandwagon of making this one of “our shows”) IMHO the show finished very strong. But whatever you…

  • Read more: The Competing Identities of Neuroethics

    The Competing Identities of Neuroethics

    By Brad Segal This past week week I attended the International Neuroethics Society’s (INS) annual conference in San Diego, California. Neuroethics is multidisciplinary field that grapples with the implications of neuroscience for—and from—medicine, law, philosophy, and the social sciences. One of the many excellent panels brought together scholars from each of these four disciplines to discuss the…

  • Read more: Kidneys and Livers, Made to Order?

    Kidneys and Livers, Made to Order?

    By Seán Finan Last week, Organovo might just have revolutionised the pharmaceutical industry. The San Diego-based company specialises in producing structures that mimic the behaviours and functions of human tissue, using 3D bioprinting. They announced last week that they were beginning the commercial manufacture and sale of their ExVive Kidney. The product models the proximal…

  • Read more: NIH Announces Plans for new Rules for Funding Chimera Research (Human-Animal Mixtures)

    NIH Announces Plans for new Rules for Funding Chimera Research (Human-Animal Mixtures)

    By I. Glenn Cohen As reported by Science, today the NIH announced plans to lift a preemptive year long moratorium on funding chimera research – that which mixes human and animal cells, often at the embryonic stage. Here is a snippet from the Science article about the new proposed NIH process: According to two notices released today, NIH is…

  • Read more: NOW ONLINE! Oxford Union Debating Society DNA Manipulation Debate

    NOW ONLINE! Oxford Union Debating Society DNA Manipulation Debate

    The Oxford Union Debating Society at Oxford University has published full video of its DNA Manipulation Debate, filmed on May 26. The Motion under debate was, “This House Believes the Manipulation of Human DNA is an Ethical Necessity.” Oxford billed its DNA Manipulation Debate as “historic” in a year when rapid advances in gene editing and genome…